APA (7th ed.) Citation

Lannering, B., Rutkowski, S., Doz, F., Pizer, B., Gustafsson, G., Navajas, A., . . . Kortmann, R. (2012). Hyperfractionated Versus Conventional Radiotherapy Followed by Chemotherapy in Standard-Risk Medulloblastoma: Results From the Randomized Multicenter HIT-SIOP PNET 4 Trial. JOURNAL OF CLINICAL ONCOLOGY, 30(26), 3187-3193. https://doi.org/10.1200/JCO.2011.39.8719

Chicago Style (17th ed.) Citation

Lannering, Birgitta, et al. "Hyperfractionated Versus Conventional Radiotherapy Followed by Chemotherapy in Standard-Risk Medulloblastoma: Results From the Randomized Multicenter HIT-SIOP PNET 4 Trial." JOURNAL OF CLINICAL ONCOLOGY 30, no. 26 (2012): 3187-3193. https://doi.org/10.1200/JCO.2011.39.8719.

MLA (9th ed.) Citation

Lannering, Birgitta, et al. "Hyperfractionated Versus Conventional Radiotherapy Followed by Chemotherapy in Standard-Risk Medulloblastoma: Results From the Randomized Multicenter HIT-SIOP PNET 4 Trial." JOURNAL OF CLINICAL ONCOLOGY, vol. 30, no. 26, 2012, pp. 3187-3193, https://doi.org/10.1200/JCO.2011.39.8719.